Skip to main content
. 2019 Nov 11;77(2):215–224. doi: 10.1001/jamaneurol.2019.3812

Figure 1. Trial Profile.

Figure 1.

AD indicates Alzheimer disease; CBS, corticobasal syndrome; mITT, modified intention to treat; OLE, open-label extension; PSP, progressive supranuclear palsy; and 4RT, 4-Repeat Tauopathy.